Antiemetic recommendations for breast cancer patients receiving highly emetogenic chemotherapy: A systematic review incorporating network meta-analyses

Authors :: Sasha Mazzarello
Terry L. Ng
Brian Hutton
Mark Clemons
Iryna Kuchuk
Joseph A. Roscoe
Source :: Journal of Clinical Oncology. 32:e17608-e17608
Publication Year :: 2014
Publisher :: American Society of Clinical Oncology (ASCO), 2014.
Abstract: e17608 Background: Despite consensus group recommendations for anti-emetic use in patients receiving highly emetogenic anthracycline and cyclophosphamide-based chemotherapy (A and C-CT), clinical e...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Chemotherapy
Anthracycline
medicine.drug_class
business.industry
medicine.medical_treatment
medicine.disease
Breast cancer
Network Meta-Analyses
Internal medicine
medicine
Antiemetic
In patient
Intensive care medicine
business
Highly emetogenic chemotherapy

Full Text Access

Tools